Healthcare

Neurotech International Ltd (ASX:NTI) has announced binding commitments to raise approximately $4.5 million through a placement aimed at advancing the company’s clinical development strategy for NTI164, its proprietary cannabinoid-based therapy targeting paediatric neurological disorders.

Embark Early Education (ASX:EVO) has announced a binding commitment for a $4.0 million institutional placement, marking another step in the company's capital management strategy. The transaction reflects the company's effort to strengthen its funding position while preparing for potential asset acquisitions. From a market …

Amplia Therapeutics (ASX: ATX) continues to attract investor attention as it advances the clinical development of its lead investigational therapy, narmafotinib. The biotechnology company's latest collaboration with Eli Lilly represents an important strategic milestone that broadens its research program into non-small cell lung cancer …

ResMed Inc (ASX:RMD) shares closed at $30.26, up 1.58%, on 3 August 2026, outperforming both the broader Australian share market and the healthcare sector during theTrading session. Meanwhile, the S&P/ASX 200 (ASX:200) closed at 9,019.30 points, up 0.47%, on 3 August 2026, while the …

Fisher & Paykel Healthcare Corporation Ltd (ASX:FPH) shares closed at $34.48, up 1.35%, on 3 August 2026, outperforming both the broader Australian market and the healthcare sector during theTrading session. Meanwhile, the S&P/ASX 200 (ASX:200) closed at 9,019.30 points, up 0.47%, on 3 August …

Sigma Healthcare Ltd (ASX:SIG) shares closed at $2.97, up 1.02%, on 3 August 2026, matching the gain recorded by the broader healthcare sector during theTrading session. Meanwhile, the S&P/ASX 200 (ASX:200) closed at 9,019.30 points, up 0.47%, on 3 August 2026, while the S&P/ASX …

CSL Ltd (ASX:CSL) shares finished theTrading sessionat $124.30, representing a 1.01% gain when the market closed on 3 August 2026. The broader Australian market also ended higher, with the S&P/ASX 200 (ASX:200) closing at 9,019.30, up 0.47%, while the S&P/ASX 200 Health Care Index …